Skip to content

Tauzin target of political attack

Former Rep. Billy Tauzin, R-La., is writing to every member of Congress to deny and denounce Democratic charges that he helped pass the 2003 prescription drug law while negotiating for his job as president of the pharmaceutical lobby.

On the basis of documents Tauzin attached to his letter and information provided by his lawyer, Tauzin definitely seems innocent of the charge, which repeatedly has been leveled as part of the Democrats’ “culture of corruption” campaign against the GOP.

Even so, Tauzin is widely cited as a trigger for two provisions of lobbying reform legislation that even Republicans are pushing in Congress: one that doubles the time before an ex-member can lobby, and the other requiring members to disclose employment negotiations.

Tauzin insists that he had nothing to disclose when, as chairman of the Energy and Commerce Committee, he helped shepherd the Medicare drug bill through to completion. President Bush signed it into law on Dec. 8, 2003, and Tauzin’s lawyer, Charles Work, first received a call from a headhunter for the pharmaceutical industry late that month.

Actual negotiations with the Pharmaceutical Research and Manufacturers Association (PhRMA) didn’t begin until Jan. 15, 2004, Work’s time sheets show. Prior to that, Tauzin told me in an interview “there were no contacts. There were no hints, no nods, no whispers, no discussions — nothing.”

In fact, he said, drug imports from Canada were down 30 percent this January “because seniors are getting access to cheaper drugs through their (Medicare) insurance plans.”

He also outlined what PhRMA is doing to repair the industry’s sour image, which, he acknowledged, is “only slightly better than members of Congress.” One program provides free drugs to 1.7 million low-income patients at a cost of $5 billion, so far.

Tauzin’s letter to members of Congress recounts his own two-year battle with duodenal cancer, including surgery, radiation and chemotherapy.

“Since Jan. 2005,” the letter says, “I have worked for the companies whose medicines literally saved my life. I am very proud of that decision. Unfortunately, during these two years and especially lately, congressional critics of my career decision have continued to repeat totally false and inaccurate claims” about negotiations with PhRMA, he wrote. “For several years now, I have endured repeated injury to my name and reputation as a result of those false claims of impropriety,” he added, asking members to stop repeating them.

The charges surfaced in a privileged resolution filed by House Minority Leader Nancy Pelosi (Calif.) in December 2005 broadly denouncing the “culture of corruption” surrounding the drug bill. It charged that Tauzin “was actively engaged in a job search with the pharmaceutical industry at the same time he was negotiating on major provisions of the bill.”

That charge has become a staple of Democratic criticism, along with claims that gasoline prices are high because of GOP connections to the oil industry and that Hurricane Katrina was badly handled because of “cronyism.”

It seems certain that “revolving door” legislation that governs the time that former members and staff are barred from lobbying will now expand from one year to two, although powerful ex-legislators such as Tauzin customarily do little actual button-holing themselves, instead giving “strategic advice” to lobbyists they employ.

Democrats are free to make hay out of the Jack Abramoff lobbying scandal and the corruption of ex-Rep. Duke Cunningham, R-Calif. And there’s no question that Republicans run the House like, as Sen. Hillary Rodham Clinton, D-N.Y., put it, a plantation.

They can attack Tauzin, if they wish, for taking the PhRMA job. But it’s wrong to say seniors aren’t being helped by the drug bill he worked on, and it’s dirty pool to charge that he was dickering with PhRMA when he wrote the bill.

Morton Kondracke is executive editor of Roll Call, the newspaper of Capitol Hill.

Leave a Comment